Superworth

Abvc Biopharma EPS ABVC

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.29
Latest quarter, Q2 FY26
−$0.03
Fiscal year 2025
−$0.39

Abvc Biopharma's earnings per share was −$0.29 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.03.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.39n/a
FY2024−$0.46n/a
FY2023−$2.52n/a
FY2022−$5.23n/a
FY2021−$5.20n/a
FY2020−$4.80n/a
FY2019−$2.00n/a
FY2018−$5.20n/a
FY2017−$3.60n/a
FY2017−$3.60n/a
FY2016−$9.00n/a
FY2013$0.00n/a
FY2012−$63000.00n/a
FY2011−$279000.00n/a
FY2010n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.03n/a−$0.29
Q1 FY26−$0.06n/a−$0.39
Q4 FY25−$0.11n/a−$0.39
Q3 FY25−$0.09n/a−$0.34
Q2 FY25−$0.13n/a−$0.28
Q1 FY25−$0.06n/a−$0.23
Q4 FY24−$0.06n/a−$0.46
Q3 FY24−$0.03n/a−$0.87
Q2 FY24−$0.08n/a−$1.66
Q1 FY24−$0.29n/a−$2.26
Q4 FY23−$0.47n/a−$2.52
Q3 FY23−$0.82n/a−$3.55

Against its peers

Companies in Drug Manufacturers - General nearest Abvc Biopharma's size, closest first, today.

CompanyEPS, 12 monthsGrowth
ABVCAbvc Biopharma−$0.29
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Abvc Biopharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.